Rutgers Health researchers have developed an oral antiviral drug candidate for COVID-19 that could overcome major limitations ...

Wang's team designed the new compound to target a structure in the virus called ... Jun13296 shows no inhibition of major drug-metabolizing CYP450 enzymes in laboratory tests, suggesting it ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Researchers at Rutgers University have created a new antiviral drug for COVID-19 that could be safer and more effective than Paxlovid, the current leading treatment. The new drug, called Jun13296, may ...

Gene editing and many other useful biotechnology tools came from studies of bacteria fighting off viral invaders. But ...

Backed Nutritional Solution Targeting Respiratory and Liver Health Through Natural Detox PathwaysSheridan, April 05, 2025 ...